Identification of the Different Roles and Potential Mechanisms of T Isoforms in the Tumor Recurrence and Cell Cycle

Junpeng Ma1, Wei Chen2, Ke Wang1

  • 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.

Oncotargets and Therapy
|February 27, 2020
PubMed
Abstract

Insights

The T-long isoform promotes chordoma recurrence, while the T-short isoform protects against it. Targeting cell cycle pathways with T isoforms influences tumor growth and apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chordomas are rare bone tumors with unclear molecular drivers.
  • T (brachyury) isoforms are implicated in development but their specific roles in chordomas are unknown.

Purpose of the Study:

  • To investigate the distinct roles and underlying mechanisms of T-long and T-short isoforms in chordoma.
  • To identify T isoforms as potential prognostic markers and therapeutic targets.

Main Methods:

  • Assessed T isoform mRNA expression in 57 chordomas and performed prognostic analysis.
  • Utilized cell apoptosis, proliferation, and cell cycle assays post-T isoform knockdown.
  • Conducted whole-transcriptome sequencing and bioinformatic analyses (GSEA, GO, KEGG, ceRNA).

Main Results:

  • T-long isoform correlated with increased tumor recurrence risk (HR=1.09), while T-short isoform showed a protective effect (HR=0.24).
  • T-long knockdown induced G0/G1 cell cycle arrest and inhibited proliferation, involving P53 signaling pathway alterations.
  • T-short knockdown caused G2/M cell cycle arrest and a trend towards increased apoptosis, potentially via YWHAZ/E2F1 pathways.

Conclusions:

  • T-long and T-short isoforms exhibit opposing roles in chordoma recurrence.
  • Cell cycle regulation is a key mechanism affected by T isoforms.
  • Downstream transcriptomic changes mediate the differential effects of T isoforms on chordoma cell behavior.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K